1 Pediatric Drugs Market Overview

• 1.1 Product Overview and Scope of Pediatric Drugs
• 1.2 Pediatric Drugs Segment by Type
  • 1.2.1 Global Pediatric Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Allergy and Respiratory Drugs
  • 1.2.3 Anti-Infectives
  • 1.2.4 Cancer Therapies
  • 1.2.5 Cardiovascular Drugs
  • 1.2.6 Central Nervous System Drugs
  • 1.2.7 Gastrointestinal Drugs
  • 1.2.8 Hormone Drugs
  • 1.2.9 Urological Drugs
• 1.3 Pediatric Drugs Segment by Application
  • 1.3.1 Pediatric Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Drugstore
• 1.4 Global Pediatric Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Pediatric Drugs Revenue 2016-2027
  • 1.4.2 Global Pediatric Drugs Sales 2016-2027
  • 1.4.3 Pediatric Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pediatric Drugs Market Competition by Manufacturers

• 2.1 Global Pediatric Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Pediatric Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Pediatric Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Pediatric Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Pediatric Drugs Market Competitive Situation and Trends
  • 2.5.1 Pediatric Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Pediatric Drugs Players Market Share by Revenue
  • 2.5.3 Global Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pediatric Drugs Retrospective Market Scenario by Region

• 3.1 Global Pediatric Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Pediatric Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Pediatric Drugs Market Facts & Figures by Country
  • 3.3.1 North America Pediatric Drugs Sales by Country
  • 3.3.2 North America Pediatric Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Pediatric Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Pediatric Drugs Sales by Country
  • 3.4.2 Europe Pediatric Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Pediatric Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Pediatric Drugs Sales by Region
  • 3.5.2 Asia Pacific Pediatric Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Pediatric Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Pediatric Drugs Sales by Country
  • 3.6.2 Latin America Pediatric Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Pediatric Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Pediatric Drugs Sales by Country
  • 3.7.2 Middle East and Africa Pediatric Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Pediatric Drugs Historic Market Analysis by Type

• 4.1 Global Pediatric Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Pediatric Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Pediatric Drugs Price by Type (2016-2021)

5 Global Pediatric Drugs Historic Market Analysis by Application

• 5.1 Global Pediatric Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global Pediatric Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global Pediatric Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Abbott Laboratories
  • 6.1.1 Abbott Laboratories Corporation Information
  • 6.1.2 Abbott Laboratories Description and Business Overview
  • 6.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Abbott Laboratories Product Portfolio
  • 6.1.5 Abbott Laboratories Recent Developments/Updates
• 6.2 Bayer
  • 6.2.1 Bayer Corporation Information
  • 6.2.2 Bayer Description and Business Overview
  • 6.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Bayer Product Portfolio
  • 6.2.5 Bayer Recent Developments/Updates
• 6.3 Boehringer Ingelheim
  • 6.3.1 Boehringer Ingelheim Corporation Information
  • 6.3.2 Boehringer Ingelheim Description and Business Overview
  • 6.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Boehringer Ingelheim Product Portfolio
  • 6.3.5 Boehringer Ingelheim Recent Developments/Updates
• 6.4 Bristol-Myers Squibb
  • 6.4.1 Bristol-Myers Squibb Corporation Information
  • 6.4.2 Bristol-Myers Squibb Description and Business Overview
  • 6.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bristol-Myers Squibb Product Portfolio
  • 6.4.5 Bristol-Myers Squibb Recent Developments/Updates
• 6.5 Colgate Oral Pharmaceuticals
  • 6.5.1 Colgate Oral Pharmaceuticals Corporation Information
  • 6.5.2 Colgate Oral Pharmaceuticals Description and Business Overview
  • 6.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Colgate Oral Pharmaceuticals Product Portfolio
  • 6.5.5 Colgate Oral Pharmaceuticals Recent Developments/Updates
• 6.6 Eli Lilly
  • 6.6.1 Eli Lilly Corporation Information
  • 6.6.2 Eli Lilly Description and Business Overview
  • 6.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Eli Lilly Product Portfolio
  • 6.6.5 Eli Lilly Recent Developments/Updates
• 6.7 Forest Laboratories
  • 6.6.1 Forest Laboratories Corporation Information
  • 6.6.2 Forest Laboratories Description and Business Overview
  • 6.6.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Forest Laboratories Product Portfolio
  • 6.7.5 Forest Laboratories Recent Developments/Updates
• 6.8 Genentech
  • 6.8.1 Genentech Corporation Information
  • 6.8.2 Genentech Description and Business Overview
  • 6.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Genentech Product Portfolio
  • 6.8.5 Genentech Recent Developments/Updates
• 6.9 GlaxoSmithKline
  • 6.9.1 GlaxoSmithKline Corporation Information
  • 6.9.2 GlaxoSmithKline Description and Business Overview
  • 6.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 GlaxoSmithKline Product Portfolio
  • 6.9.5 GlaxoSmithKline Recent Developments/Updates
• 6.10 Johnson & Johnson
  • 6.10.1 Johnson & Johnson Corporation Information
  • 6.10.2 Johnson & Johnson Description and Business Overview
  • 6.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Johnson & Johnson Product Portfolio
  • 6.10.5 Johnson & Johnson Recent Developments/Updates
• 6.11 MedImmune
  • 6.11.1 MedImmune Corporation Information
  • 6.11.2 MedImmune Pediatric Drugs Description and Business Overview
  • 6.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 MedImmune Product Portfolio
  • 6.11.5 MedImmune Recent Developments/Updates
• 6.12 Merck
  • 6.12.1 Merck Corporation Information
  • 6.12.2 Merck Pediatric Drugs Description and Business Overview
  • 6.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Merck Product Portfolio
  • 6.12.5 Merck Recent Developments/Updates
• 6.13 Novartis Pharmaceuticals
  • 6.13.1 Novartis Pharmaceuticals Corporation Information
  • 6.13.2 Novartis Pharmaceuticals Pediatric Drugs Description and Business Overview
  • 6.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Novartis Pharmaceuticals Product Portfolio
  • 6.13.5 Novartis Pharmaceuticals Recent Developments/Updates
• 6.14 Novo Nordisk
  • 6.14.1 Novo Nordisk Corporation Information
  • 6.14.2 Novo Nordisk Pediatric Drugs Description and Business Overview
  • 6.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Novo Nordisk Product Portfolio
  • 6.14.5 Novo Nordisk Recent Developments/Updates
• 6.15 Pfizer
  • 6.15.1 Pfizer Corporation Information
  • 6.15.2 Pfizer Pediatric Drugs Description and Business Overview
  • 6.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Pfizer Product Portfolio
  • 6.15.5 Pfizer Recent Developments/Updates
• 6.16 Pharmacia
  • 6.16.1 Pharmacia Corporation Information
  • 6.16.2 Pharmacia Pediatric Drugs Description and Business Overview
  • 6.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Pharmacia Product Portfolio
  • 6.16.5 Pharmacia Recent Developments/Updates
• 6.17 Roche
  • 6.17.1 Roche Corporation Information
  • 6.17.2 Roche Pediatric Drugs Description and Business Overview
  • 6.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Roche Product Portfolio
  • 6.17.5 Roche Recent Developments/Updates
• 6.18 Schering-Plough
  • 6.18.1 Schering-Plough Corporation Information
  • 6.18.2 Schering-Plough Pediatric Drugs Description and Business Overview
  • 6.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Schering-Plough Product Portfolio
  • 6.18.5 Schering-Plough Recent Developments/Updates

7 Pediatric Drugs Manufacturing Cost Analysis

• 7.1 Pediatric Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Pediatric Drugs
• 7.4 Pediatric Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Pediatric Drugs Distributors List
• 8.3 Pediatric Drugs Customers

9 Pediatric Drugs Market Dynamics

• 9.1 Pediatric Drugs Industry Trends
• 9.2 Pediatric Drugs Growth Drivers
• 9.3 Pediatric Drugs Market Challenges
• 9.4 Pediatric Drugs Market Restraints

10 Global Market Forecast

• 10.1 Pediatric Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Pediatric Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Pediatric Drugs by Type (2022-2027)
• 10.2 Pediatric Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Pediatric Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Pediatric Drugs by Application (2022-2027)
• 10.3 Pediatric Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Pediatric Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Pediatric Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs

Segment by Application
Hospital
Clinic
Drugstore

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough